Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amyris, Inc. stock logo
AMRS
Amyris
$0.54
$0.05
$4.86
$18.47M1.1912.59 million shs46.75 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amyris, Inc. stock logo
AMRS
Amyris
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Amyris, Inc. stock logo
AMRS
Amyris
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amyris, Inc. stock logo
AMRS
Amyris
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amyris, Inc. stock logo
AMRS
Amyris
$269.85M0.00N/AN/A($1.52) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amyris, Inc. stock logo
AMRS
Amyris
-$528.51M-$1.93N/AN/AN/A-229.12%N/A-80.35%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Amyris, Inc. stock logo
AMRS
Amyris
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amyris, Inc. stock logo
AMRS
Amyris
N/A
0.52
0.29

Institutional Ownership

CompanyInstitutional Ownership
Amyris, Inc. stock logo
AMRS
Amyris
62.76%

Insider Ownership

CompanyInsider Ownership
Amyris, Inc. stock logo
AMRS
Amyris
36.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amyris, Inc. stock logo
AMRS
Amyris
1,598369.39 million235.30 millionOptionable

Recent News About These Companies

Amyris, Inc. (AMRS)
Founder relaunches Costa Brazil after Amyris bankruptcy
Amyris Receives Court Approval for Restructuring Plan
Dr. Reddy's acquires MenoLabs from Amyris
Dr. Reddy’s Laboratories acquires MenoLabs from Amyris
Naomi Watts buys back her Stripes brand from bankrupt Amyris portfolio
Amyris to sell JVN brand for $1.25M
Amyris stock logo

Amyris NASDAQ:AMRS

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.